Dovetail Genomics, LLC

Biotech · Acquired

In vitro proximity-ligation method and computational software for de novo metagenomics assembly of fecal samples to characterize gut microbiome composition

Claim this profile

Follows are private to you and power your alerts

Updated

Sector
Biotech
Total capital
$5.1M
Federal grants
$5.1M
6 awards · 2015–2018
Rank in peer group#5 of 13
Private capital raised
None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
Federal contracts
None on recordNo federal contract awards found.
Granted patents
11
29 pending · first 2017
Rank in peer group#2 of 13

Capital timeline

2015201620172018FEDERAL ↑EQUITY ↓Cumulative $5.1M$1.5M$150K$761K$225K$1.7M$771K
2015201620172018FEDERAL ↑EQUITY ↓Cumulative $5.1M$1.5M$761K$1.7M$771K

Latest events

  • Federal grantHealth and Human S · Phase II · A rapid, culture-free whole genome approach for characterizing complex metagenomics samples$771K
  • Federal grantHealth and Human S · Phase II · A rapid, culture-free whole genome approach for characterizing complex metagenomics samples$1.7M
  • Federal grantHealth and Human S · Phase I · A method for the preservation of long-range genomic information during DNA storage and transport.$225K
  • Federal grantHealth and Human S · Phase II · An in vitro method for generating long-range read pair data for genomic assembly and analysis.$761K
  • Federal grantHealth and Human S · Phase I · A new method for long-range haplotype phasing with short-read sequencing data.$150K
  • Federal grantHealth and Human S · Phase II · An in vitro method for generating long-range read pair data for genomic assembly and analysis.$1.5M

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 13 peers

Line = median

Biotech · System

  • Federal grants#5 · top 38%
  • Granted patents#2 · top 15%
  • Linked publications#3 · top 23%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

No founders are linked to this company yet.

Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.

Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026

Claim this profile to add your team

What it has protected

USPTO · 11 granted of 40
  • PendingTagging Nucleic Acids For Sequence AssemblyUSPTOApplication 19660829
  • PendingSample Prep For Dna Linkage RecoveryUSPTOApplication 19242575
  • PendingGeneration Of Phased Read-sets For Genome Assembly And Haplotype PhasingUSPTOApplication 19233810
Show all 40 patent records
  • Tagging Nucleic Acids For Sequence AssemblySep 10, 2026 · Application 19660829Pending
  • Sample Prep For Dna Linkage RecoveryMay 14, 2026 · Application 19242575Pending
  • Generation Of Phased Read-sets For Genome Assembly And Haplotype PhasingMay 7, 2026 · Application 19233810Pending
  • Nucleic Acid Sequence AssemblyDec 25, 2025 · Application 19037646Pending
  • Generation Of Phased Read-sets For Genome Assembly And Haplotype PhasingOct 2, 2025 · Application 19236454Pending
  • Tagging Nucleic Acids For Sequence AssemblyOct 2, 2025 · Application 18949657Pending
  • Generation Of Phased Read-sets For Genome Assembly And Haplotype PhasingSep 2, 2025 · US 12,404,537Granted
  • Sample Prep For Dna Linkage RecoveryAug 5, 2025 · US 12,378,592Granted
  • Methods And Compositions For Proximity LigationJul 3, 2025 · Application 19085841Pending
  • Recovering Long-Range Linkage Information From Preserved SamplesJun 5, 2025 · Application 18768466Pending
  • Methods And Compositions For Sequencing Library PreparationFeb 27, 2025 · Application 18939781Pending
  • Methods For Human Leukocyte Antigen Typing And PhasingFeb 13, 2025 · Application 18780961Pending
  • Tagging Nucleic Acids For Sequence AssemblyDec 31, 2024 · US 12,180,535Granted
  • Dendrimers For Genomic Analysis Methods And CompositionsSep 12, 2024 · Application 18665851Pending
  • Recovering Long-Range Linkage Information From Preserved SamplesAug 20, 2024 · US 12,065,691Granted
  • Methods And Compositions For Sequencing Library PreparationMar 14, 2024 · Application 18270027Pending
  • Physical Linkage Preservation In Dna StorageNov 7, 2023 · US 11,807,896Granted
  • Nucleic Acid Sequence AssemblyJun 8, 2023 · Application 18163421Pending
  • Nucleic Acid Sequence AssemblyMar 7, 2023 · US 11,600,361Granted
  • Methods And Compositions For Proximity LigationAug 25, 2022 · Application 17620034Pending
  • Nucleic Acid Characteristics As Guides For Sequence AssemblyDec 2, 2021 · Application 16605158Pending
  • Recovering Long-Range Linkage Information From Preserved SamplesMar 16, 2021 · US 10,947,579Granted
  • Structural Variant AnalysisOct 8, 2020 · Application 16762619Pending
  • Methods For Genome Assembly, Haplotype Phasing, And Target Independent Nucleic Acid DetectionApr 30, 2020 · Application 16562312Pending
  • Tagging Nucleic Acids For Sequence AssemblyJan 7, 2020 · US 10,526,641Granted
  • Methods For Genome Assembly, Haplotype Phasing, And Target Independent Nucleic Acid DetectionOct 29, 2019 · US 10,457,934Granted
  • Nucleic Acid Sequence AssemblyJun 11, 2019 · US 10,318,706Granted
  • Nucleic Acid Sequence AssemblyJul 25, 2017 · US 9,715,573Granted
  • Dendrimers For Genomic Analysis Methods And CompositionsApplication PCTUS2022050291Pending
  • Methods For Human Leukocyte Antigen Typing And PhasingApplication PCTUS2023011549Pending
  • Methods And Compositions For Sequencing Library PreparationApplication 63490192Pending
  • Methods And Compositions For Sequencing Library PreparationApplication 63715197Pending
  • Methods And Compositions For Sequencing Library PreparationApplication PCTUS2023021682Pending
  • Methods For Human Leukocyte Antigen Typing And PhasingApplication 63515956Pending
  • Analysis Of Nucleic Acids From Preserved SamplesApplication 63721287Pending
  • Analysis Of Nucleic Acids From Preserved SamplesApplication PCTUS2025055143Pending
  • Nucleic Acid Sequence AssemblyApplication 18375220Pending
  • Methods of Haplotype PhasingApplication 63624222Pending
  • Methods And Compositions For Sequencing Library PreparationApplication 63216170Pending
  • Methods for Haplotype PhasingApplication 63558054Pending

Recent research by its founders

  • iSCORE-PD: an isogenic stem cell collection to research Parkinson’s disease20265 cites
  • hockemeyer-ucb/pd-sv-analysis: v120260 cites
  • iSCORE-PD: an isogenic stem cell collection to research Parkinson's Disease20260 cites
  • Entrada TherapeuticsSimilar federal contract value in Biotech · null in contracts
  • Pelage PharmaceuticalsSimilar federal contract value in Biotech · null in contracts
  • Hexagon Bio Inc.Similar federal contract value in Biotech · null in contracts
  • SimBioSys, Inc.Similar federal contract value in Biotech · null in contracts
  • Xilio TherapeuticsSimilar federal contract value in Biotech · null in contracts
  • EvozyneSimilar federal contract value in Biotech · null in contracts

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .